-
1 Comment
Lattice Biologics Ltd is currently in a long term downtrend where the price is trading 19.2% below its 200 day moving average.
From a valuation standpoint, the stock is 99.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.5.
Lattice Biologics Ltd's total revenue sank by 32.2% to $475K since the same quarter in the previous year.
Its net income has dropped by 285.1% to $-269K since the same quarter in the previous year.
Finally, its free cash flow fell by 748.5% to $-147K since the same quarter in the previous year.
Based on the above factors, Lattice Biologics Ltd gets an overall score of 1/5.
Industry | Biotechnology |
---|---|
Sector | Healthcare |
ISIN | CA5184101056 |
CurrencyCode | CAD |
Exchange | V |
Beta | -11.68 |
---|---|
Dividend Yield | 0.0% |
Target Price | None |
PE Ratio | None |
Market Cap | 5M |
Lattice Biologics Ltd., a biotech company, develops, manufactures, and markets biologic products for use in the field of bone regeneration in dental, spine, and general orthopedic indications worldwide. It develops novel amniotic fluid-based products, such as AmnioBoost and AmnioBlast. The company also offers traditional, spinal, particulate, soft tissue, dental, membrane and barrier, and demineralized bone matrix allografts. Its products are used in a range of applications, including enhancing fusion in spine surgery and breast reconstruction post mastectomy, promotion of bone regeneration in foot and ankle surgery, promotion of skull healing following neurosurgery, enhancing wound repair in burn victims, hernia repair, and subchondral bone defect repair in knee and other joint surgeries, as well as sports medicine indications, such as anterior and posterior cruciate ligament repair. The company is headquartered in Belgrade, Montana.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for LBL.V using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2024